Developed in collaboration with Yuwell Medical, Voxi 5 presents a viable option for patients seeking reliable stationary oxygen therapy, delivering 1-5 L/min of quiet 1, pure 2, continuous flow oxygen ...
Inogen INGN shares ended the last trading session 5% higher at $13.35. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to ...
Inogen (INGN +5.2%) rose pre-market following its Q4 results on Feb. 24 post market. Q4 total revenue rose 3.3% Y/Y to $76.4M, missing analysts' estimates of $76.60M. The increase was mainly driven by ...
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com ...
It has been about a month since the last earnings report for Inogen (INGN). Shares have lost about 5.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results